A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma
about
The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirusIdentification of two novel members of erbA superfamily by molecular cloning: the gene products of the two are highly related to each otherStructural and functional studies of the intracellular tyrosine kinase MATK gene and its translated productActivated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosoureaThe ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous systemv-maf, a viral oncogene that encodes a "leucine zipper" motifMolecular biology of lung cancer: clinical implicationsInhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigenyes-related protooncogene, syn, belongs to the protein-tyrosine kinase familyCorrelation of the structure of the transmembrane domain of the neu oncogene-encoded p185 protein with its functionInhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancersExpression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.Cloning and expression of a gene encoding an interleukin 3 receptor-like protein: identification of another member of the cytokine receptor gene familyc-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming potential.Involvement of pp60c-src with two major signaling pathways in human breast cancer.Molecular cloning and characterization of a novel cytoplasmic protein-tyrosine phosphatase that is specifically expressed in spermatocytes.Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosineSHP2 binds catalase and acquires a hydrogen peroxide-resistant phosphatase activity via integrin-signaling.A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like propertiesPhosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppressionStructure of the human insulin receptor gene and characterization of its promoter.Amplification of the proto-neu oncogene facilitates oncogenic activation by a single point mutation.The int-2 gene product acts as an epithelial growth factor in transgenic miceOverexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanismsGenomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization.Heregulin β-1 induces loss of cell-cell contact and enhances expression of MUC1 at the cell surface in HCC2998 and MKN45-1 cells.Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.Identification and biochemical characterization of p70TRK, product of the human TRK oncogene.Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.Stage- and tissue-specific expression of the neu oncogene in rat development.Polymersomes as an effective drug delivery system for glioma--a review.Testing for HER2 in Breast Cancer: A Continuing Evolution.Cancer genetics and tumor antigens: time for a combined view?Markers of bile duct tumorsCharacterization of the promoter region of the human c-erbB-2 protooncogeneTrastuzumab-based combination therapy for breast cancer.Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin geneNeu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines
P2860
Q22254864-4657FC05-7CCD-444B-B643-4FED4FC10D6DQ24294014-15669FDA-425F-4473-90F5-600BE51A4DA0Q24306629-ED7E2313-B57F-4BDA-A580-6F966D2BD3C7Q24594880-A6319A47-86A9-4627-BF39-8E3419789CADQ24601534-A4A33DD7-C1F1-4E6E-B20C-342F8C569C5CQ24605815-36490052-A30E-48F8-8CAD-329D7C990B99Q24610335-8B5B08A1-437F-42A4-B10D-FD12833E94D7Q24628627-411C93EF-BB57-4BC9-9A1D-981DD3514DD3Q24630485-97E5318A-4DF8-48FA-81D4-3CDA1141E88DQ28259722-E8E2EE7A-8170-4160-89D7-9B4E8167724CQ28375856-5345F630-79D6-4A73-B32D-B2609C7EF193Q28570541-DADD0586-834E-4E5F-976D-44193D34B23AQ28592999-AF9AC652-8C44-4A54-B6C6-0BFC77E3540FQ30157161-ECF47C47-AE69-478B-A5CA-E1F9AAA4EDC1Q30194582-0C656B92-8710-4DCB-A340-21B36AEFDCE2Q32170454-744F0931-BC9D-45DD-9AE4-AEADE067877BQ33216759-1CEA6AD4-864A-479B-9635-530AE4731A8CQ33292562-2930A070-17CC-428C-8ED9-43E730FD15A0Q33557958-84A7810E-7AD4-42EF-AE92-E00CBAD65C48Q33576592-6B9D8AA2-A34A-429D-8082-C98E68FF8502Q33634356-2AC84362-1DCA-4DE3-BADF-B1858A22C4D0Q33688434-BF6E2169-E38F-4FF7-8091-2913D395718DQ33828120-7344C71F-D6AC-429F-B184-9BCF7CD65097Q33849412-086E4C34-A720-42D2-98AB-5C098E7F700BQ33918611-1DAF7241-2AB4-4450-BBA3-C3D51709426FQ33928879-0031F9AA-0E21-426E-95C0-1057211DF3F2Q33979826-956517C1-DF87-413B-BB2A-F7817EC1C930Q34117767-3F373579-F911-4C98-82F2-B0C484CAC2FFQ34348403-568DD4F4-4A58-46E6-9EE3-E45A83B66A18Q34348845-D0AAF963-87A9-44BA-ABFC-DB4A12FDA141Q34353519-839B08E6-A136-4A1B-84D5-60AD54B84490Q34372027-BC857B8D-3E0C-4695-B571-EF19F29620F1Q34420100-3E7B31F7-C914-45B2-95A8-881425D9437CQ34424285-C2DC6176-FB9C-4FBE-946F-FCAE8BAC6C15Q34495646-D56FB59D-17F4-4159-A9A1-3C2EE30F771EQ34628852-9C4559C6-DB75-4D14-A04A-430F5799F50FQ34633898-A4CC519A-2C2B-461C-BC8C-C38D1312814EQ35609686-75E1AA7D-A895-4EDC-92B6-C056BBFC14C5Q35621568-E5F2AEAE-1990-4093-887D-AFD05EC476CFQ35830913-83A9F338-75F8-41AA-879F-4FDAAF08A8DB
P2860
A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
A v-erbB-related protooncogene ...... salivary gland adenocarcinoma
@ast
A v-erbB-related protooncogene ...... salivary gland adenocarcinoma
@en
type
label
A v-erbB-related protooncogene ...... salivary gland adenocarcinoma
@ast
A v-erbB-related protooncogene ...... salivary gland adenocarcinoma
@en
prefLabel
A v-erbB-related protooncogene ...... salivary gland adenocarcinoma
@ast
A v-erbB-related protooncogene ...... salivary gland adenocarcinoma
@en
P2093
P2860
P356
P1476
A v-erbB-related protooncogene ...... salivary gland adenocarcinoma
@en
P2093
P2860
P304
P356
10.1073/PNAS.82.19.6497
P407
P577
1985-10-01T00:00:00Z